With the advancement of medical technology, the methods of drug administration have become more and more diverse. Among them, buccal administration has attracted attention for its unique drug delivery mechanism. This method of administration is to place the drug in the cheek and directly enter the blood circulation through the oral mucosa, which means that the drug can avoid the first-pass effect of the liver faced by traditional oral drugs and may provide better bioavailability and Rapid drug response.
Intrabuccal medications do not need to pass through the digestive system and can enter the bloodstream more effectively, making the therapeutic effect faster and more direct.
The benefits of buccal drug delivery are obvious, especially for patients who cannot swallow medication normally, this method provides a convenient solution. The study pointed out that the drug dosage forms presented in buccal form, including buccal tablets and films, can not only effectively treat pain, but also manage a variety of diseases, including mental illness and epilepsy.
Intrabuccal drug delivery has made significant progress in clinical practice. The following are some common intrabuccal drugs:
Drug administration through the oral mucosa can not only reduce the digestive system decomposition of drugs, but also increase the duration of therapeutic effect.
The mechanism of intrabuccal drug delivery depends mainly on the structure of the oral mucosa. After the drug enters the oral cavity, it enters the body's circulation through the cheek mucosa, avoiding the acidic environment of the gastrointestinal tract, thereby protecting the stability and effectiveness of the drug. Drugs penetrate the oral mucosa mainly through the intracellular pathway
and the intercellular pathway
, which affect the absorption and bioavailability of drugs.
Intrabuccal medications offer several potential advantages, including:
However, this method of drug delivery is not without its challenges. The taste of many medications may affect patient compliance and may also cause side effects such as oral irritation.
Unsuitable drugs and their side effects may limit patients' use, limiting the popularity of buccal administration.
The preparation of intrabuccal drugs usually needs to take into account their bioadhesion and solubility in the oral cavity. During the formulation process, it is often necessary to add adhesives and penetration enhancers to improve the bioavailability of drugs. Furthermore, the manufacturing of these dosage forms should focus on how to reduce the washout effect of saliva, which is a key factor in improving its efficacy.
With the in-depth research on buccal drug delivery technology, this field is still full of potential, and it is possible to develop more buccal drug delivery solutions for specific diseases in the future. How to effectively utilize the advantages of this technology to overcome current limitations will become the focus of the industry.
In this age of rapid technological change, can we expect buccal administration to become the main choice for drug delivery in the future?